Przemysław Trzeciak

ORCID: 0000-0003-4790-291X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Acute Myocardial Infarction Research
  • Cardiac Imaging and Diagnostics
  • Mechanical Circulatory Support Devices
  • Coronary Interventions and Diagnostics
  • Atrial Fibrillation Management and Outcomes
  • Lipoproteins and Cardiovascular Health
  • Health Systems, Economic Evaluations, Quality of Life
  • Cardiac Valve Diseases and Treatments
  • Venous Thromboembolism Diagnosis and Management
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Heart Failure Treatment and Management
  • Cardiac Arrest and Resuscitation
  • Cardiac Health and Mental Health
  • Infective Endocarditis Diagnosis and Management
  • Cardiovascular Disease and Adiposity
  • Cardiovascular Function and Risk Factors
  • Cardiac Structural Anomalies and Repair
  • Cardiac pacing and defibrillation studies
  • Global Health Care Issues
  • Viral Infections and Immunology Research
  • Healthcare Systems and Public Health
  • Cardiac, Anesthesia and Surgical Outcomes
  • Trauma and Emergency Care Studies
  • Cardiovascular Issues in Pregnancy
  • Diabetes, Cardiovascular Risks, and Lipoproteins

Silesian Center for Heart Disease
2016-2025

Medical University of Silesia
2016-2025

Medical University of Lodz
2023

Greater Poland Cancer Center
2021

Górnośląskie Centrum Medyczne
2003-2013

Kardio-Med Silesia
2005-2006

Patients after acute myocardial infarction (AMI) are at very high cardiovascular (CV) risk. Therefore, appropriate management of dyslipidemia with adequate lipid-lowering therapy is crucial for preventing subsequent CV events in these patients.Our analysis aimed to assess the treatment and attainment low-density lipoprotein cholesterol (LDL-C) goals patients AMI who participated Managed Care Acute Myocardial Infarction Survivors (MACAMIS) program.This study a retrospective consecutive agreed...

10.33963/kp.a2023.0045 article EN Kardiologia Polska 2023-04-28

Introduction Lipoprotein(a) [Lp(a)] is an independent risk factor for atherosclerotic cardiovascular disease (ASCVD). Increased Lp(a) concentration > 30 mg/dl (75 nmol/l) and especially >50 (125 may cause faster atherosclerosis, being important underdiagnosed residual factor. Thus, there a need to characterize further the clinical phenotypes in patients at ASCVD with high levels now during follow-up, while also looking possible impact of geographical differences. Material methods The...

10.5114/aoms/188294 article EN cc-by-nc-sa Archives of Medical Science 2024-05-06

Thanks to advances in interventional cardiology technologies, catheter-directed treatment has become recently a viable therapeutic option the of patients with acute pulmonary embolism at high risk early mortality. Current transcatheter techniques allow for local fibrinolysis or embolectomy minimal complications. Therefore, these procedures can be considered high-risk as an alternative surgical when systemic thrombolysis is contraindicated ineffective. They are also intermediate-high-risk who...

10.33963/kp.a2023.0075 article EN Kardiologia Polska 2023-04-28

Thanks to advances in interventional cardiology technologies, catheter-directed treatment has become recently a viable therapeutic option the of patients with acute pulmonary embolism at high risk early mortality. Current transcatheter techniques allow for local fibrinolysis or embolectomy minimal complications. Therefore, these procedures can be considered high-risk as an alternative surgical when systemic thrombolysis is contraindicated ineffective. They are also intermediate-high-risk who...

10.33963/kp.a2023.0075 article EN cc-by-nc-nd Kardiologia Polska 2023-01-01

Background Neointima forming after stent implantation consists of vascular smooth muscle cells (VSMCs) in 90%. Growth factors TGF-β1, PDGFB, EGF, bFGF and VEGF-A play an important role VSMC proliferation migration to the tunica intima arterial wall injury. The aim this paper was analysis functional polymorphisms genes encoding relation in-stent restenosis (ISR). Materials Methods 265 patients with a stable coronary artery disease (SCAD) hospitalized our center years 2007–2011 were included...

10.1371/journal.pone.0150500 article EN cc-by PLoS ONE 2016-03-01

Risk-factor identification and risk stratification are prerequisites to the effective primary secondary prevention of cardiovascular disease (CVD). Patients at highest benefit most from intensive risk-factor reduction. However, high-risk patients' group is heterogeneous, it increasingly recognised that there an 'extreme-risk' category patients who may require particularly close attention therapeutic approach. The aim this study was identify subgroups death following myocardial infarction...

10.1016/j.atherosclerosis.2021.08.024 article EN cc-by-nc-nd Atherosclerosis 2021-08-13

Background: Cardiogenic shock (CS) remains the leading cause of poor prognosis in patients with acute myocardial infarction (AMI), sustaining a high mortality rate 40 to 50% within 30 days. Aims: In this unique analysis two national all-comers, real-life registries including AMI complicated by CS, for whom early revascularization was planned, we aimed compare effect percutaneous coronary (PCI) and artery bypass grafting (CABG) on 30-day 1-year all-cause mortality. Methods: The study included...

10.33963/v.phj.104782 article EN Kardiologia Polska 2025-02-18

Background: Despite the introduction of concept known as "Chain Survival" has significantly increased survival rates in patients with out-of-hospital cardiac arrest (OHCA), short-term mortality this group is still very high. Epidemiological data on OHCA Poland are limited. The aim study was to create a prospective registry covering population 2.7 million inhabitants Upper Silesia Poland. Presented herein design and results 3-month pilot study. Methods: Silesian Registry Out-of-Hospital...

10.5603/cj.a2018.0140 article EN Cardiology Journal 2013-01-02

INTRODUCTION Patients under the age of 40 years represent from 1% to 6% all patients with acute myocardial infarction (AMI). OBJECTIVES We aimed analyze recent trends in clinical presentation, treatment, and both in‑hospital 12‑month outcomes ST‑segment elevation (STEMI) non‑STEMI (NSTEMI), treated 2009 2013. PATIENTS AND METHODS The study included 1639 young AMI PL‑ACS registry (1.3% AMI). Trends period 2010 (643 patients) 2012 2013 (676 were analyzed. RESULTS percentage admissions for...

10.20452/pamw.4092 article EN Polskie Archiwum Medycyny Wewnętrznej 2017-08-23

Mechanical circulatory support (MCS) methods are used in patients with both acute and chronic heart failure, who have exhausted other options for pharmacological or surgical treatments. The purpose of their use is to support, partially completely, the failed ventricles ensure adequate organ perfusion, which allows restore full cardiovascular capacity, prolonging life effectively improving its quality. three most popular devices include an intra-aortic balloon pump (IABP), percutaneous assist...

10.33963/kp.a2021.0169 article EN Kardiologia Polska 2021-12-29

Background: Substantial differences in survival after out-of-hospital cardiac arrest (OHCA) have been observed between countries. These might be attributed to the organization of emergency medical service (EMS) systems, including prehospital physician involvement. However, limited data exist on physician’s role improving OHCA. Aims: To compare and in-hospital outcomes OHCA patients attended by physician-staffed EMS vs. paramedic-staffed units. Methods: Among all enrolled regional,...

10.33963/kp.a2022.0109 article EN Kardiologia Polska 2022-06-30

Background: Mitral regurgitation (MR) is frequently observed in patients with myocardial infarction (MI). However, the incidence of severe MR contemporary population unknown. Aims: The study evaluates prevalence and prognostic impact ST-segment elevation (STEMI) non-ST-segment (NSTEMI). Methods: group consisted 8062 enrolled Polish Registry Acute Coronary Syndromes (PL-ACS) years 2017–2019. Only full echocardiography performed during index hospitalization were eligible. primary composite...

10.33963/kp.a2023.0064 article EN Kardiologia Polska 2023-06-29

Out-of-hospital cardiac arrest (OHCA) remains a leading cause of global mortality, while survivors are burdened with long-term neurological and cardiovascular complications. OHCA management at the hospital level challenging, due to heterogeneity presentation, critical status patients reaching return spontaneous circulation (ROSC), demands post ROSC treatment. The validity optimal timing for coronary angiography is one important, yet not fully defined, component management. Guidelines state...

10.5603/cj.a2023.0032 article EN cc-by-nc-nd Cardiology Journal 2023-05-12

Despite significant advances in interventional cardiology and mechanical circulatory support (MCS) techniques, outcomes for patients with myocardial infarction (MI) complicated by cardiogenic shock (CS) remain suboptimal. This expert consensus aims to provide information on the current management of MI CS Poland propose solutions, including systemic ones, all stages care. The document uses data from Polish PL-ACS Registry Acute Coronary Syndromes, which includes records more than 820 000...

10.33963/v.kp.97817 article EN PubMed 2023-01-01

There is a paucity of data concerning the clinical characteristics, management, and outcomes coronary artery bypass graft surgery (CABG) in patients ≤ 45 years old.We aimed to compare in-hospital long-term > old, who underwent isolated CABG.We identified consecutive had CABG Department Cardiac Surgery Transplantology Silesian Centre for Heart Diseases Zabrze between January 2006 December 2011 were enrolled Polish National Registry Procedures (KROK registry). A total 8196 split into two...

10.5603/kp.a2017.0090 article EN Kardiologia Polska 2017-05-29
Coming Soon ...